Recently, some groups have reported that the combination of RAF inhibitors and MEK inhibitors shows significant synergistic anti-tumor effects in melanoma with v-raf murine sarcoma viral oncogene homolog B1 (BRAF) V600E mutation [26,27]. This evidence concerns the gene MAP2K7 and melanoma.